Thomas Decker Christensen, Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Aarhus University Hospital, Skejby, DK - 8200 Aarhus N, Denmark.
Thromb Haemost. 2011 Sep;106(3):391-7. doi: 10.1160/TH11-04-0217. Epub 2011 Jun 9.
Children and adolescents on oral anticoagulation therapy (OAT) present special challenges in terms of rapid fluctuations in International Normalised Ratio (INR) values, interruption in daily life due to frequent hospital/doctor visits, and difficulties and pain in the performance of venepuncture. Optimised management of OAT improves the quality of treatment, potentially accomplished by new methods such as patient self-testing (PST) and patient self-management (PSM). A review was performed, identifying 11 trials with children and adolescents. All studies had different methodological problems, predominantly by being non-randomised trials. A total of 284 patients were included with a mean follow-up of 22 months, finding a time within therapeutic INR target range between 63% and 84%. The coagulometers used for estimating the INR values were found to have sufficient precision and accuracy for clinical use, but external quality control is probably advisable. It can be concluded that PST and PSM are at least as good treatment options as conventional management in highly selected children. Larger studies, preferably randomised, controlled trials using clinical endpoints, are obviously needed in order to elucidate whether these new regimens of treatment are superior to conventional management of oral anticoagulation therapy.
接受口服抗凝治疗(OAT)的儿童和青少年在国际标准化比值(INR)值快速波动、因频繁就诊于医院/医生而中断日常生活、以及静脉穿刺的困难和疼痛等方面带来了特殊挑战。OAT 的优化管理可以提高治疗质量,这可能通过新的方法来实现,如患者自我检测(PST)和患者自我管理(PSM)。我们进行了一项综述,共纳入了 11 项针对儿童和青少年的试验。所有研究都存在不同的方法学问题,主要是非随机试验。共有 284 名患者入组,平均随访 22 个月,发现治疗 INR 目标范围内的时间在 63%至 84%之间。用于估计 INR 值的凝血仪被发现具有足够的精度和准确性,可用于临床使用,但可能需要进行外部质量控制。可以得出结论,PST 和 PSM 至少与传统管理一样,是高度选择的儿童的治疗选择。显然需要进行更大规模的研究,最好是使用临床终点的随机对照试验,以阐明这些新的抗凝治疗方案是否优于传统管理。